2026-10-22 22:13 UTC
Personalized mRNA cancer vaccine cut melanoma death, recurrence by 42%
Markers released top-line results today after previously reporting trial succeeded.
https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
Replies (4)
-
@bjc@shangdu.kublai.com 2026-10-22 22:16
@arstechnica@mastodon.social stuff like this sounds exciting, but the "personalized" is the give-away. this isn't for us, this is to keep our already ancient ruling class alive even longer. this should be a celebration, but it's just more damnation
-
@scottytrees@mastodon.social 2026-10-22 23:41
@arstechnica@mastodon.social all these advancements are nice and all, but I feel like most of us aren’t gonna have access to this because everything is about money and power instead of about community building.
-
@peoplearepower@mastodon.social 2026-10-23 04:46
@arstechnica@mastodon.social Who, in their right mind, is still trusting any mRNA platform?
-
@borisschapira@framapiaf.org 2026-10-23 04:48
@Siestacorta@mastodon.parleur.net 🍒